Elevated expression of MAN2B1 has been found in several cancers, including bladder urothelial carcinoma, breast invasive carcinoma, colon adenocarcinoma, glioblastoma multiforme, low-grade gliomas, and laryngeal cancer (96, 97). Here, MAN2B1 is linked to bladder transitional cell carcinoma.